Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial

BACKGROUND: The antidiabetic and hypoglycemic effects of chitosan have been reported in previous studies. We have previously shown that chitosan oligosaccharide reduces postprandial blood glucose levels in vivo. We conducted a short-term crossover study to support the results of the previous study....

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Sarang, Min Cho, Jung, Kwon, Young-In, Kim, Seong-Chul, Yeob Shin, Dong, Ho Lee, Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828684/
https://www.ncbi.nlm.nih.gov/pubmed/31685797
http://dx.doi.org/10.1038/s41387-019-0099-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828684/
https://www.ncbi.nlm.nih.gov/pubmed/31685797
http://dx.doi.org/10.1038/s41387-019-0099-4

Ejemplares similares